Betamethasone Ointment Market Worldwide Industry Analysis, Future Demand and Forecast till 2029

Betamethasone Ointment Market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market during the forecast period include increasing incidences of skin disorders such as psoriasis, rising incidences of asthma, surge in cancer patients, and rising incidences of rheumatoid disorders such as rheumatoid arthritis and systemic lupus erythematosus. Betamethasone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes).

Betamethasone belongs to a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Furthermore, the advent of different formulations of betamethasone and untapped market opportunities in emerging nations will further boost the market growth. In order to maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships and collaborations, and mergers and acquisitions. For instance, in March 2020, Lupin Ltd. declared the launch of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%, having received an approval from the US Food and Drug Administration (US FDA) earlier. The product would be manufactured at Lupin's Pithampur (Unit III) facility, India. It is the generic equivalent of Diprolene Ointment, 0.05%, of Merck Sharp and Dohme Corp. It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older.

To Request a Sample of our Report on Betamethasone Ointment Market: https://www.omrglobal.com/request-sample/betamethasone-ointment-market

Market Coverage

• The market number available for - 2022-2030

• Base year- 2022

• Forecast period- 2023-2030

Segment Covered-

• By Type

Regions covered-

• North America

• Europe

• Asia-Pacific

• Rest of the World

Competitive Landscape: GlaxoSmithKline plc, Merck & Co., Inc., and Cipla Inc., among others.

A full Report of Betamethasone Ointment Market is Available @ https://www.omrglobal.com/industry-reports/betamethasone-ointment-market

Betamethasone Ointment Market Report by Segment

By Type

• Betamethasone Dipropionate

• Betamethasone Sodium Phosphate

• Betamethasone Valerate

Global Betamethasone Ointment Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

• Latin America

• Middle East and Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/betamethasone-ointment-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.